Skip to main content

Human Health

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation. 

scientists in laboratory
Ridgefield Research building

Our U.S. Innovation Hub

Our U.S. headquarters in Ridgefield, Conn. is home to one of Boehringer Ingelheim’s leading research and development sites with expertise across research, development and translational medicine and clinical pharmacology.

Read more
our pipeline

Our Human Pharma Research and Development Pipeline

With a pipeline of around 80 clinical and pre-clinical projects, and the potential to deliver up to 20 new medicine approvals in the next six years, we continue our track record of long-term innovation-led performance.

Read more

Latest Articles on Human Health

Welcome to Innovation @ Boehringer Ingelheim
dna helix graphic
Human Health Innovation

Welcome to Innovation @ Boehringer Ingelheim

Find out how we’re translating new ideas and new science into breakthrough medicines at Boehringer Ingelheim.
Read more
Research and Development
how we discover banner
Fostering Science | Boehringer Ingelheim US

Research and Development

As a global pharmaceutical company, the discovery and development of innovative medicines is fundamental to our continued growth and success.
Read more

Related Press Releases